242 related articles for article (PubMed ID: 28598238)
1. NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.
Karki R; Malireddi RKS; Zhu Q; Kanneganti TD
Cell Cycle; 2017 Jul; 16(13):1243-1251. PubMed ID: 28598238
[TBL] [Abstract][Full Text] [Related]
2. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer.
Karki R; Man SM; Malireddi RKS; Kesavardhana S; Zhu Q; Burton AR; Sharma BR; Qi X; Pelletier S; Vogel P; Rosenstiel P; Kanneganti TD
Nature; 2016 Dec; 540(7634):583-587. PubMed ID: 27951586
[TBL] [Abstract][Full Text] [Related]
3. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
4. NLRC3 inhibits PDGF-induced PASMCs proliferation via PI3K-mTOR pathway.
Zha LH; Zhou J; Tan Y; Guo S; Zhang MQ; Li S; Yan P; Yu ZX
J Cell Physiol; 2020 Dec; 235(12):9557-9567. PubMed ID: 32383265
[TBL] [Abstract][Full Text] [Related]
5. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
6. Dihydromethysticin, a natural molecule from Kava, suppresses the growth of colorectal cancer via the NLRC3/PI3K pathway.
Pan H; Liu F; Wang J; Zhao M; Wang D; Jia C; Wang T; Chen Z; Fan Y; Liang D; Meng Q
Mol Carcinog; 2020 Jun; 59(6):575-589. PubMed ID: 32187756
[TBL] [Abstract][Full Text] [Related]
7. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
[TBL] [Abstract][Full Text] [Related]
8. The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis.
Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM
Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845
[TBL] [Abstract][Full Text] [Related]
9. The Green Walnut Husks Induces Apoptosis of Colorectal Cancer through Regulating NLRC3/PI3K Pathway.
Chen C; An N; Pang D; Cheng Y; Chen Y; Feng X; Lei H; He W; Yang B; Zhang Y; Zhao X
Curr Pharm Des; 2023; 29(12):940-946. PubMed ID: 37005539
[TBL] [Abstract][Full Text] [Related]
10. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
11. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
12. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.
Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L
Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389
[TBL] [Abstract][Full Text] [Related]
13. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Stefani C; Miricescu D; Stanescu-Spinu II; Nica RI; Greabu M; Totan AR; Jinga M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638601
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction.
Dai J; Sun Y; Chen D; Zhang Y; Yan L; Li X; Wang J
Eur J Pharmacol; 2019 Dec; 864():172724. PubMed ID: 31600493
[TBL] [Abstract][Full Text] [Related]
15. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
16. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
17. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
[TBL] [Abstract][Full Text] [Related]
18. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
[TBL] [Abstract][Full Text] [Related]
19. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
20. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma.
Granato M; Rizzello C; Romeo MA; Yadav S; Santarelli R; D'Orazi G; Faggioni A; Cirone M
Int J Biochem Cell Biol; 2016 Oct; 79():393-400. PubMed ID: 27620077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
